Gewinn- und Verlustrechnung von Amtech Systems, Inc.

ASYS' 79% rally reflects AI-driven packaging demand, a surging TPS backlog, wider margins and stronger liquidity heading into fiscal 2027.

Semtech (NASDAQ: SMTC - Get Free Report) and Amtech Systems (NASDAQ: ASYS - Get Free Report) are both technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation. Risk and Volatility Semtech has a beta of 2.35,

Trio-Tech and Amtech serve distinct semiconductor equipment markets, but which stock is better positioned to create long-term shareholder value? Let's dive in.

Silicon Laboratories (NASDAQ: SLAB - Get Free Report) and Amtech Systems (NASDAQ: ASYS - Get Free Report) are both technology companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends. Risk and Volatility Silicon Laboratories has a beta

ASYS' bookings rise 33% as AI-driven TPS demand surges, lifting backlog and extending order visibility into fiscal 2027.

Amtech Systems (ASYS) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, ASYS crossed above the 20-day moving average, suggesting a short-term bullish trend.

From a technical perspective, Amtech Systems (ASYS) is looking like an interesting pick, as it just reached a key level of support. ASYS recently overtook the 200-day moving average, and this suggests a long-term bullish trend.

ASYS' TPS revenues jump 24.9% as AI-related sales surge, while strong bookings and orders point to more growth ahead.

AXT leads Amtech Systems on AI-driven InP demand, earnings growth and capacity expansion, despite a premium valuation and advanced-packaging momentum.

ASYS' AI-driven growth, margin gains and strong backlog support momentum, but weak SFS demand and a premium valuation warrant caution.